Status:
UNKNOWN
Paracervical Block in Laparoscopic Hysterectomy
Lead Sponsor:
Kangbuk Samsung Hospital
Conditions:
Uterine Fibroid
Adenomyosis
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
It remains controversial whether paracervical block should be performed as a powerful strategy for pain relief in total laparoscopic hysterectomy (TLH), because convincing conclusions are difficult to...
Detailed Description
Postoperative pain management is an important component of patient care and satisfaction after surgery. Although contemporary changes such as a shift to minimally invasive approaches and an introducti...
Eligibility Criteria
Inclusion
- age between 18 and 65 years
- American Society of Anesthesiologists physical status (ASAPS) classification I-II
- the absence of pregnancy at the time of surgery
Exclusion
- history of cervical surgery such as conization or cerclage
- inability to perform the paracervical block due to anatomical abnormalities (i.e., very atrophic or small cervix)
- allergy to bupivacaine, planned concomitant surgical procedures involving extensive additional tissue manipulation such as pelvic lymph node dissection
- any concomitant surgery of pelvic floor repair (uterosacral ligament suspension or sacrocolpopexy) or vaginal procedures (anterior or posterior colporrhaphy or mid-urethral slings), previously taking opioids for chronic pain
- inability to accurately express their pain
Key Trial Info
Start Date :
February 21 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2021
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT03792009
Start Date
February 21 2019
End Date
February 1 2021
Last Update
February 25 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 03181
2
Kangbuk Samsung Hospital
Seoul, South Korea, 110-746
3
Wonju Severance Christian Hospital
Wŏnju, South Korea